Dr. Zelalem Temesgen

zaelDr. Zelalem Temesgen MD is Professor of Medicine at Mayo Clinic, where he directs the Mayo Clinic HIV program, the Mayo Clinic Global HIV Education Initiative, and the Mayo Clinic Center for Tuberculosis. In addition to clinical responsibilities, Dr. Temesgen is actively involved in education and research both within Mayo Clinic and extramurally, participating in the clinical teaching curriculum for the Mayo Medical School and the Mayo Graduate School of Medicine as well as the Infectious Diseases Division. He is the founder of the Mayo Clinic Global HIV Education Initiative, which has developed a number of programs to enhance the knowledge and proficiency of health care providers worldwide. These include: Fundamentals of Global HIV Medicine, an HIV Management book intended for HIV medical care providers in resource limited settings, written by more than 60 subject matter experts from 15 countries; HIV eCurriculum series, an innovative, self-paced online program that has enrolled over 1600 learners in the United States and 700 professionals in Ethiopia; the tuberculosis eCurriculum Series, development of a web-based national Ethiopian curriculum on tuberculosis and leprosy; development of a web-based national Ethiopian curriculum on HIV testing and counseling; and HIV-Link, mobile phone-based clinical consultative support for HIV practitioners in rural Southern Ethiopia. Additional activities include media presentations, extramural visiting professorships and invited lectures at national and international meetings. Dr. Temesgen is the author of numerous publications, sits on the editorial boards of several medical journals, and is editor-in-chief of two books: Mayo Clinic Infectious Diseases Board Review Book and Fundamentals of Global HIV Medicine. Dr. Temesgen currently serves as the chair of the American Academy of HIV Medicine and a member of the US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Dr. Temesgen has previously served as a member of the United States Presidential Advisory Council on HIV/AIDS as well as a member of the Scientific Advisory Board for The US President’s Emergency Plan for AIDS Relief (PEPFAR).